Skip to content
Pharma Observatory a Scientist.com platform
  • Supplier site
  • Group of sites (click to zoom)

Scientist.com supplier network (site locations)

Research supplier

Boston Strategic Partners

Boston Strategic Partners is listed as a small business research supplier in the Scientist.com network, with 1 site in 1 country.

View Boston Strategic Partners on Scientist.com

Sign in to Scientist.com to open this supplier in your organization's marketplace.

Email me this page as a PDF

Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Sites 1
Countries 1

Services

What this research supplier says it provides, as listed in the Scientist.com network.

Type of company: Small business

Brand Communications

  • Patient-HCP Communication Aids Design and development of tools (visuals, guides, devices) that facilitate clear, accurate, and empathetic two-way dialogue between patients and their healthcare providers.

Clinical Consulting

  • Biostatistics Consulting Apply statistical theory and mathematical principals to research
  • Clinical Protocol Design & Development Creation of clinical protocol document which details how a clinical trial is designed, relating to to the methodology, hypothesis, and operation of clinical trial to ensure the safety of the patients is...
  • Clinical Trial Feasibility Request services related to Clinical Trial Design and feasibility.
  • IND Writing Consulting Consulting for an Investigational New Drug Application
  • Medical Science Liason (MSL) The primary purpose of the MSL role is to establish and maintain peer-peer relationships with leading physicians, referred to as Key Opinion Leaders (KOL’s), at major academic institutions and clinics.
  • Regulatory Consulting Ensure that each product or device complies with all FDA rules and regulations.
Show all 7 in Clinical Consulting 1 more
  • Study Budgeting Consulting Request for Consulting Services

Clinical Trials

  • Clinical Trial Design Develop study-related protocols, case report forms (CRFs) and database tools for records management.
  • Phase 1-3 Studies Design phase 1-3 studies that seek to identify if a drug is safe, effective, and more efficient than other available treatments on the market.
  • Post-Marketing (Phase 4) Studies Conduct phase 4 studies for confirming unrecognized safety issues, investigating possible hazards or establishing the expected safety profile of a veterinary medicinal product under market conditions.
  • Prospective Explorative Studies Conduct a prospective exploratory study to assess the safety and efficacy of a test drug during clinical trials.
  • Regulatory Affairs Consulting Receive assistance ensuring compliance with regulatory requirements.
  • Site Selection Select clinical trial sites with clinicians who recruit, enroll, treat and evaluate trial patients.
Show all 7 in Clinical Trials 1 more
  • Study/Site Feasibility Study Explore and test study practicality.
Show all 192 services 179 more

Commercial Consulting

  • Portfolio Management Manage a portfolio of projects in early-stage drug discovery and provide factors that determine the success of the proposed portfolio.

Creative

  • Case Studies Recruit research participants with a behavioral condition to receive either an investigational behavioral intervention or a behavioral intervention in clinical use.
  • Infographic Create a quick visual representation of information, data or knowledge.
  • Product Marketing Bring a product to market.

Data Science/Bioinformatics

  • Biostatistical Design Use statistics to ensure appropriate pre-clinical and clinical study design.
  • Clinical Data Analysis Analysis that helps you make sense of your clinical data
  • Clinical Data Science and Modeling A process that helps make sense of your clinical data
  • Clinical Imaging Diagnostic Analysis An analytical approach to analyzing biological images for diagnostic purposes.
  • Clinical Machine Learning/AI Complex analytical approaches to find patterns and make predictions in drug discovery projects
  • Clinical Responder Analysis, Patient Stratification The process of identifying patients that are more likely to respond positively to a drug.
Show all 28 in Data Science/Bioinformatics 22 more
  • Clinical Trial Integration Analysis The process of combining data from multiple clinical trials to understand categories of drugs and drug behavior in a more global way.
  • Discovery Data Analysis Analysis that helps you make sense of your discovery data
  • Discovery Data Integration The process of combining different complex data types together to make it easier to understand or analyze.
  • Discovery Data Management A process that includes acquiring, validating, storing, protecting, and processing required data to ensure the accessibility, reliability, and timeliness of the data for its users.
  • Discovery Data Science and Modeling A process that helps make sense of your discovery data
  • Discovery Databases Databases specifically designed for drug discovery use.
  • Discovery Machine Learning/AI Complex analytical approaches to find patterns and make predictions in drug discovery projects.
  • Discovery Omics Analytics A process to analyze various omics data (genomics, transcriptomics, proteomics, metabolomics, etc.) This can include the integration of different omics data. Helps to better understand the molecular environment...
  • Discovery Predictive Analytics Analytical approaches to predict how a drug target behaves in a given environment.
  • Discovery Software Tools Software designed to serve the needs of discovery research groups.
  • Discovery Statistical and Mathematical Modeling Use mathematical variables and equations to establish relationships between data.
  • RWE/HEOR Data Management A process that includes acquiring, validating, storing, protecting, and processing required data to ensure the accessibility, reliability, and timeliness of the data.
  • RWE/HEOR Data Science and Modeling A process that helps make sense of your clinical data
  • RWE/HEOR Drug/Therapy Discontinuation Analysis An analysis to understand patient behavior. Are the drugs taken on time, do the patients discontinue use, and if so how long after starting, etc.
  • RWE/HEOR Machine Learning/AI Complex analytical approaches to find patterns and make predictions in RWE/HEOR projects
  • RWE/HEOR Market Analysis A process to understand how a drug is performing in the market and possible opportunities in the market
  • RWE/HEOR Software Tools Software designed to serve the needs of RWE/HEOR research groups.
  • Translational Data Analysis Analysis that helps you make sense of your translational data
  • Translational Data Harmonization and Integration Process to combine different data together for better understanding and analysis of the integrated data.
  • Translational Data Management A process that includes acquiring, validating, storing, protecting, and processing required data to ensure the accessibility, reliability, and timeliness of the data.
  • Translational Data Science and Modeling A process that helps make sense of your translational data
  • Translational Machine Learning/AI Complex analytical approaches to find patterns and make predictions in drug discovery projects.

Drug Development

  • Consulting Services Work with consultants who provide expert advice in various areas of research and technology.
  • Pharmacology Consulting Request consulting services related to pharmacology and the chemical properties, biological effects, and therapeutic uses of drugs.

General Marketing

  • Database Management Software Facilitate the collection, tracking and processing of biological facts, statistics and observations.

HEOR

  • Clinical Outcome Assessments (Non-Patient Reported) Measure a patient's symptoms, mental state and level of disease condition-related impact on daily life.
  • Clinical Outcomes Measures patient's symptoms, mental, or physical effects of a disease or condition on how the patient functions, recorded by practitioner, provider, or instrument (not by patient).
  • Comparative Effectiveness The generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition or to improve the delivery of care.
  • Cost Benefit Analysis Economic evaluation in which costs and benefits (outcomes) are expressed in monetary units, to determine if the benefits of an intervention outweigh the costs.
  • Cost Effectiveness Analysis Compare alternative treatments that lead to similar health outcomes.
  • Decision Analytic Modeling Assess effects, costs and economic outcomes of treatment. These include cost-effectiveness models and budget impact models.
Show all 13 in HEOR 7 more
  • Health Economics and Outcomes Research (HEOR) Evaluate data collected during drug development to maximize the value of a therapeutic product.
  • HEOR Adherence Studies Strategy or study that assess extent to which patients or subjects follow recommendations for prescribed intervention; may include compliance assessment, as well as reasons related to actual or potential non-adherence.
  • Patient Reported Outcomes (PRO) Assessment of health outcomes directly reported by the patient who experienced it, without interpretation of the patient's response by a clinician.
  • Patient Treatment Patterns Assessment of treatment processes and patterns within clinical practice.
  • Resource Utilization Descriptive and/or analytical review of a treatment that investigate the marketing, distribution, prescription, and use of drugs in populations. Endpoints to be assessed are the medical, social, and economic outcomes.
  • Systematic Literature Review Summarizes the results of research (that meet pre-defined eligibility criteria for inclusion) and provides a high level of evidence on the outcomes assessed.
  • Therapy Switch Insight into the reasoning of patients switching treatments and the outcomes of the switch.

Market Access

  • Communication & Advertisement Distribution of a range of materials, through various communication channels, to highlight a message containing scientific-related topics
  • Emerging Market Opportunities Analyze risks and opportunities in new markets and ensure patients have timely and continued access to new treatments.
  • Formulary & Reimbursement Strategy Develop strategy and narrative to gain formulary access on insurance plans.
  • Health Technology Assessment (HTA) Preparation/Strategy Dossier Development Perform evidence preparation and/or create strategies for the systematic evaluation of the properties, effects, and/or impacts of health care technology.
  • Health Technology Assessment Submission (HTA Submission) Analyze the medical, social, ethical, humanistic, and economic considerations of a drug, medical device, or clinical procedures. Submissions are sent to regulatory agencies with different requirements that govern...
  • Market Access Materials Find general strategies and methods used to market a pharmaceutical product or device.
Show all 11 in Market Access 5 more
  • Market Research & Business Intelligence Run market feasibility studies, establish customer needs, improve product performance and analyze competition.
  • Marketing and Commercialization Identify, promote and prove the value of a particular drug to key stakeholders.
  • Pricing Strategy Develop value story tailored to a payer audience that will determine the appropriate price for treatment.
  • Value Based Agreements or Outcomes-Based Contracts Collaborate with payer or provider to develop a reimbursement plan outside of the traditional fixed cost-per-unit that ties reimbursement or price to actual health outcomes.
  • Value Dossiers Development Summary document that presents clinical, economic, and humanistic value of an intervention and associated disease state with the supporting evidence, formulated from the perspective of a particular stakeholder...

Medical Communications

  • Abstracts Request services related to the writing and review of abstracts
  • Animated Content Development of diverse visual, interactive digital assets like infographics, data visualizations, and short animations to explain complex medical and scientific concepts simply.
  • Case Reviews Review medical cases from Clinical Trials.
  • Communication Plan Communications plan enables organizations and corporations to effectively deliver information to appropriate stakeholders and customers.
  • Competitive Intelligence Develop a coordinated competitive intelligence program which contains a systematic collection and analysis of information from multiple sources about a specific business's industry.
  • Congress Listening/Insights Report Systematic collection, analysis, and summary of key discussions, scientific trends, competitor movements, and data presented at major medical congresses.
Show all 42 in Medical Communications 36 more
  • Consensus reports Develop and submit a report that is a comprehensive examination by an expert panel of a scientific or medical issue.
  • Data Visualization Visualize data collected from clinical trials and/or clinical research.
  • Delegate Logistics Managing the travel, accommodation, registration, and related administrative needs for attendees of investigator meetings, advisory boards, or congresses.
  • Distribution Strategy & Channel Recommendations Developing plans for how and where medical content (e.g., publications, training, MOA videos) will be efficiently delivered to the target healthcare audience.
  • Gap Analysis Compare the actual performance of an organization or corporation with potential or desired performance, as ways to effectively analyze resource management or allocation.
  • KEE Identification, Mapping & Engagement Planning Systematic process to identify, categorize, and strategically plan outreach to Key External Experts (KEEs) based on their influence, specialization, and research activity.
  • KOL Engagement & Management Building and maintaining compliant, value-driven relationships with Key Opinion Leaders (KOLs) to collaborate on scientific exchange and clinical education initiatives.
  • Landscape Analysis Find a cohesive and consistent view of your main organization. Develop initiatives in analyzed areas of operations and analyze chosen key aspects of them.
  • Market & Competitor Analyses Evaluating the current therapeutic landscape, identifying unmet needs, and assessing the scientific positioning and data of competitor products.
  • Mechanism of Disease (MOD) & Mechanism of Action (MOA) Videos Production of dynamic, scientifically accurate animated videos illustrating how a disease develops (MOD) and how a drug therapeutically affects the body (MOA).
  • Medical Affairs Dossiers Develop medical affairs dossiers such as Global Value Dossiers or AMCP Dossiers.
  • Medical letters, Emails & Customized Responses Drafting accurate, balanced, and compliant answers to unsolicited scientific and medical inquiries from healthcare professionals or consumers.
  • Medical Literature Reviews Systematic searching, appraisal, and synthesis of published scientific literature to generate evidence-based reports on a specific topic, disease, or treatment.
  • Medical Publications Make clear and accurate presentations of scientific and technical data.
  • Medical Q&As Developing pre-approved, standardized documents containing accurate, balanced answers to anticipated scientific inquiries about a product or disease.
  • Medical Science Liaison (MSL) External Presentation Develop and design Medical Science Liaison External Presentations.
  • Medical Science Liaison (MSL) Support Support services for Medical Science Liaisons (MSL).
  • Medical Science Liasion (MSL) Training Training for medical science liaisons who want to work in pharmaceutical, biotechnology, medical device, and managed care companies.
  • Medical Writing and Editing/Manuscript Development Communicate scientific, technical and health-related information to a range of audiences.
  • Other Medical Affairs Videos Develop and design Medical Affair videos that are explainer videos and or augmented/virtual reality experiences.
  • Patient Narratives Compliant collection and use of individual patient stories to illustrate the impact of a disease or treatment, often for training or empathy-building purposes.
  • Payer Directed Communication Tools (other than Dossiers) Request services related to payer directed communication tools.
  • Pharmacodynamic/ Pharmacokinetic Reports Create Pharmacodynamic/ Pharmacokinetic reports to report to the appropriate regulatory bodies.
  • Poster Design and Development Design and Develop Posters for Poster Symposiums and conferences to effectively convey science information.
  • Poster Symposia, Summits, Product Theaters, etc. Support Comprehensive planning and execution support for organized, large-scale medical meetings and events used to present and discuss clinical data and research.
  • Protocol and Study Reports Write protocol and study reports, specifically relating to the drafting, writing, and editing of Clinical Safety Reports.
  • Publication Writing Create further publication documents. Investigational device exemptions (IDEs) BLAs, MAA, PMA, eCTDs, informed consents, CMC and manufacturing reports, orphan drug designations (ODD), briefing books.
  • Publications Plan Development & Management Strategic planning and oversight of all research dissemination activities, including outlining target journals, timelines, authors, and compliance for clinical data publications.
  • Quality Control/ Quality Assurance Documents Develop quality control or quality assurance documents.
  • Review Article/ Submission Drafting and managing the process of submitting an objective, comprehensive summary of the current literature on a disease or treatment area to a peer-reviewed journal.
  • Sales Training Modules Develop and distribute sales training modules.
  • Sales Training Webinar Slide Decks Develop slide decks for sales training webinars.
  • Scientific Platform Develop a rigorous approach to creating a core story (grounded in the scientific literature) for a product. This involves identifying core concepts that address disease states, clinical needs, and product-related...
  • Scientific Training Solutions Developing comprehensive educational programs and materials to ensure internal teams, field medical staff, or external partners are fluent in the therapeutic area and product data.
  • Strategic Medical Communication Development & Planning High-level planning to define the core scientific messages and the tactical strategy needed to effectively convey clinical data to key stakeholders over time.
  • Target Product Profile (TPP) A sponsor prepared document which summarizes the drug development program that is described in terms of the labelling concepts. This profile is a communication method used between the FDA and sponsor which can be used...

Medical/Commercial

  • Health & Pharmacoeconomics Identify, measure and compare the cost-benefit ratio of products and services.
  • Life Cycle Assessment (LCA) Analyze the lifecycles of the products and services with regard to their environmental impacts.

Old Category HEOR, RWE, Market Access

  • Health Technology Assessment Submission (HTA Submission) (DUPLICATE) Conduct a multidisciplinary process that determines the value of a health technology through different points in its lifecycle.
  • Non-Interventional Studies Examine different aspects of drug usage, including efficacy and safety, under real-life conditions.
  • Patient-Reported Outcome Studies Get self-reported information regarding the personal health status of an individual.
  • RWE/RWD Enriched Studies Combine different methodologies (retrospective, prospective, registries, chart or claims review, electronic medical/health records) to gain insights into real world patient behavior or drug use.

Real World Evidence & Data

  • Claims Data - Billing Includes patient demographics, insurance status, geographical location, among others.
  • Claims Data - Medical Includes hospitalization,physician visits,emergency department visits. May or may not include laboratory information including resource utilization, costs or charges, as well as ICD-9 or 10 codes.
  • Claims Data - Pharmacy Includes medications, prescription orders, payment submissions, patient adherence, among others.
  • Clinical Data Registry A study or collection of data regarding the health of patients and the care they receive over different time periods.
  • Clinical Phenotype Data Obtain phenotypic data and observations on patients such as the clinical manifestation of the disease, clinical and behavioral parameters, symptoms, and laboratory test results.
  • Data Asset Validation Tools for validating that patient data and source has been accurately recorded.
Show all 32 in Real World Evidence & Data 26 more
  • Data Merging Tools for combining various data sets into a single data set. Includes data consolidation.
  • Exploratory Study Explore study design, outcomes, data-collection method, and selection of population for a topic that needs more research information.
  • HealthVerity - Health Data Platform HealthVerity platform serves as the foundation for the rapid creation, exchange and management of healthcare and consumer data. Through best-in-class identity resolution and matching capabilities, increased...
  • Meta-Analysis Use quantitative statistical approaches to pool results across multiple studies to improve power or resolve uncertainty; may be used in conjunction with a systematic review.
  • Multi-Source Data Pools Multiple data sources aggregated into singular platforms for analysis. May or may not include real-time analytics capabilities.
  • Non-Comparative Study Assess an intervention using a single arm study design (without a control or comparator group).
  • Patient Reported Outcomes (PRO) Databases Database or collection of data related to health outcomes directly reported by the patient who experienced it, without interpretation of the patient's response by a clinician or anyone else.
  • Pragmatic Clinical Trial Randomized trial comparing two or more treatments in a real world setting. The trial possesses minimal exclusion criteria and closely follows the procedures of the clinical practice in order to mirror clinical care...
  • Pregnancy Registries Database containing, through utilizing observational research methods, standardized data about women taking medication or vaccines while pregnant. Data may also collected on the newborn.
  • Real World Evidence (RWE) Studies Studies (prospective or retrospective) utilizing data obtained from "real world settings" , and is outside the tight controls of a clinical trial design.
  • Real-World Data Acquire real-world data from patients' electronic medical records including clinical information generated during the course of healthcare.
  • Real-World Evidence Acquire clinical data from patients' medical records to analyze trends and the frequency of occurrence of different medical conditions.
  • Registries - Disease Database containing, through utilizing observational research methods, standardized data about patients who have the same disease.
  • Registries - Patient Database containing, through utilizing observational research methods, standardized data about patients who have the same condition, disease, or exposure and is used to evaluate an outcome
  • Registries - Product Includes specific information about a product of interest, route of administration, dose, duration of use, start and stop date.
  • Retrospective Exploratory Studies Retrospective exploratory studies
  • RWD - COVID-19 Data from COVID-19 patients, can include diagnosis, treatment, among others.
  • RWD - Diagnostics/Laboratory Includes information on laboratory procedures/results.
  • RWD - Electronic Medical Record (EMR) Digital version of a patient's medical or health chart containing demographic, clinical, medical, and other treatment information.
  • RWD - Genomics Genomic data collected from a patients with different diseases, can be derived from a range of sources.
  • RWD - Oncology Data from oncology patients, can include clinical treatment, diagnosis, among others.
  • RWD - Rare Diseases Data from patients with rare diseases, can include clinical treatment, diagnosis, among others.
  • RWD - Wearables Data gathered from sources including pedometers, mobile devices, smart watches, among others.
  • RWE/HEOR Data Analysis Analysis that helps you make sense of your RWE/HEOR data
  • RWE/RWD Observational Research Research method for documenting clinical, economic, and or humanistic outcomes of actual medical practice absent the constraints of a more formal experimental design. See also Pragmatic Clinical Trials.
  • Secondary Real World Evidence Analyze clinical trial data.

Regulatory Affairs

  • Life Cycle Management Plan and strategy of the data collection and information throughout the different phases of product development (portfolio assessment, pre-clinical trials, clinical trials, pre-authorization, post-authorization, and RWE)
  • Medical Labeling Design and create medical labels that accurately reflect purpose, precautions and other information.
  • Patient Risk Management Identify, contain, and manage risks related to patient safety.
  • Period Benefit Risk Evaluation Report (PBRER) Preparation of safety reports to report adverse events that occurred during a specified time period. Evaluate if safety profile of treatment has changed since last report
  • Post Authorization Efficacy Study (PAES) Answer uncertainties in efficacy of treatment, and improve understanding of treatment and the benefit-risk profile. These studies are specifically asked for by European Medicines Agency (EMA) to continually grant...
  • Post Authorization Safety Study (PASS) Evaluate the safety, benefit-risk profile, and risk management of a treatment. These studies are specifically asked for by European Medicines Agency (EMA) and they can be mandatory or voluntary.
Show all 11 in Regulatory Affairs 5 more
  • Post-authorization Safety Studies Research efforts conducted after a drug has been approved for market to monitor its safety profile in the general population. These studies aim to identify, characterize, or quantify potential adverse effects...
  • Regulatory Submission Documents Request services related to the submission and writing of New Drug Applications (NDA), Investigational New Drugs (INDs), and Investigator Brochures (IB) to the FDA and other regulatory bodies.
  • Risk Benefit Assessment Determine ratio of treatment risk to the potential benefits.
  • Risk Evaluation & Mitigation Strategy (REMS) Evidence required by FDA to support the benefit of treatment outweighs the risks. Purpose of REMS is to prevent, monitor, and manage serious risk by informing, educating, and reinforcing actions to reduce frequency...
  • Safety Signals Early indication that a new or unknown adverse event occurred that may be caused by treatment and investigation is needed to determine a causal relationship. Can be investigated through spontaneous reports, studies...

Scientific Data Services

  • Bayesian Statistics Extract information from data sets that are subject to error or noise to see unobserved possibilities.
  • Bioinformatics Bioinformatics is a powerful method of storing, retrieving and analyzing biological data.
  • Cancer Systems Biology Convert complex molecular data obtained from high-throughput technologies to deducible information.
  • Cloud Computing Request on-demand computer resources specifically relating to large data storage and computing power.
  • Data and Text Mining Derive structured data from free text in order to become accessible for data-mining algorithms.
  • Data Curation Organize and integrate data collected from various sources to ease data discovery and retrieval.
Show all 22 in Scientific Data Services 16 more
  • Data Infrastructure Design and deploy an information management solution suited to users' specific needs.
  • Data Lineage & Quality Track the various processes through which data has been created, edited or exchanged.
  • Data Quality Framework Manage data quality issues to maintain good quality data outputs.
  • Database Integration Convert bioinformatics results from multiple data sources (DSs) into a single operational format.
  • Epigenomics Data Analysis Quantify and analyze DNA methylation and/or DNA binding protein data sets.
  • Machine Learning/ AI Predict and model an outcome (e.g. disease progression) based on input variables (i.e. features.)
  • Metabolomics Data Analysis Use metabolites to identify any potential biomarkers or novel therapeutic targets that may play a role in the mechanisms responsible for the progression of a disease.
  • Metagenomics Data Analysis Deconvolute the genetic content of genomes contained in environmental samples by utilizing whole genome sequencing techniques to provide insight into microbial communities and host phenotypes.
  • Microbiome Data Analysis Determine the population composition of a microbial community and analyze its contribution to human or animal health.
  • Mutation Data Profiling Guide treatment decisions in cancer based on the identification of genomic mutations .
  • Omics Informatics Consulting Services for the analysis of large-scale molecular data sets.
  • Scientific Data Visualization Exploration and reporting of data by means of graphs and plots.
  • Scientific Pipeline Implementation Design, develop and deploy data analyses workflows.
  • Semantic Tech & Triplestores Store and retrieve semantic facts.
  • System Development Plan, create and deploy an information system.
  • Systems Network Analysis Analyze and visualize molecular pathways including gene regulatory, protein-protein and drug-target networks.

Other services

  • IND Writing Receive assistance with materials for an IND application.
  • NDA Writing Receive assistance in the NDA application process.
  • Observational Research Gain valuable insights into the association between a drug treatment and its outcomes such as long-term effectiveness and safety.
  • Plain Language Summaries Request services related to the creation of plain language summaries.
  • Trial Awareness Create awareness about a clinical trial.
Website
bostonsp.com

Source: Scientist.com supplier network

Where it operates

Sites by country, with the cities in each.

  • United States Boston 1 site

Source: Scientist.com supplier network (site locations)

Supplier diversity

SAM.gov small-business designations

Minority-owned

US small-business federal-contractor designation, self-certified in the U.S. federal System for Award Management (SAM.gov). Coverage is limited to matched U.S. small-business suppliers, so an absent designation is not evidence of its absence.

Source: U.S. federal System for Award Management (SAM.gov), self-certified by the supplier

Get the Boston Strategic Partners report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Sources: Scientist.com supplier network, U.S. federal System for Award Management (SAM.gov).

Work with Boston Strategic Partners on Scientist.com

For prices, more details, or to contact Boston Strategic Partners, visit Scientist.com.

Sign in to Scientist.com to open this supplier in your organization's marketplace.